Research News and Research

RSS

D-cycloserine helps patients learn how to conquer their fears

The fear of public speaking is the most common among individuals with SAD, as well as in the general population. The results of the study are published in the March issue of the Archives of General Psychiatry.

13 Mar 2006

Completely novel approach to fighting HIV infections

For more than a year, researchers watched patiently as a few computer-simulated HIV protease molecules squirmed into more than 15,000 slightly different shapes. In real time, this contortion takes only a fraction of a second.

13 Mar 2006

New test for detecting small amounts of proteins in the blood

Researchers at the University of Pennsylvania School of Medicine have developed a paradigm-shifting method for detecting small amounts of proteins in the blood.

13 Mar 2006

Transplanting a pair of kidneys with limited function into one patient may offer one solution to short supply of donated kidneys

Transplanting a pair of kidneys with limited function into one patient can be just as successful as the standard procedure in which a patient receives a single kidney, according to new research at Wake Forest University Baptist Medical Center.

13 Mar 2006

Insulin levels in African American children worsen as they progress through puberty

...while those same levels don't change in their Caucasian counterparts, says new University of Alberta research that shows puberty is a key developmental period affecting diabetes risk.

13 Mar 2006

Tinnitus and its effect on working memory and attention

Individuals with chronic, moderate tinnitus do more poorly on demanding working memory and attention tests than those without tinnitus, according to research conducted at the University of Western Sydney.

13 Mar 2006

Health disparities in heart attack hospital transfer patterns

Older, female and minority patients rushed to community hospitals with acute heart attacks are less likely to be transferred to a larger hospital that offers procedures to immediately open clogged arteries, Duke University Medical Center cardiologists have found.

13 Mar 2006

Trial explores safety and efficacy of injecting human stem cells directly into the brain to treat fatal pediatric neurodegenerative disorder

Researchers in Doernbecher Children's Hospital at Oregon Health & Science University will begin a Phase I clinical trial using stem cells in infants and children with a rare neurodegenerative disorder that affects infants and children.

13 Mar 2006

Disturbance of serotonin can lead to sudden infant death syndrome

University of Chicago researchers and colleagues have found strong support that a disturbance of a specific neurochemical can lead to sudden infant death syndrome, the primary cause of death before age 1 in the United States.

13 Mar 2006

Dental professionals can play a pivotal role in detecting and reporting violence against women

The impact of domestic violence has been recognized as a health care crisis by organizations all over the world. Twenty-five percent of American women have reported abuse at the hands of their spouses or domestic partners.

13 Mar 2006

Drug-eluting stents best treatment for managing coronary restenosis

In the first published trial of its kind, a multi-center clinical study has shown that drug-eluting stents outperform the current "gold standard" radiation treatment in managing coronary restenosis and in preventing further clogging of coronary arteries.

13 Mar 2006

Positive effects of tight blood glucose control can be seen more than a decade later in diabetics

People with diabetes who keep their blood sugar in check today will probably have a far lower chance of developing foot pain or other nerve damage tomorrow, according to new research results from a national study.

9 Mar 2006

Early periodontal treatment leads to lower medical costs

Chronic conditions such as diabetes mellitus (DM), coronary artery disease (CAD), and cerebrovascular disease (CVD) have been associated with periodontal disease.

9 Mar 2006

Nematode hormone discovery may aid fight against parasitic disease

New research at UT Southwestern Medical Center shows that on a biochemical level, hormone-like molecules in tiny worms called nematodes work similarly to the way in which certain hormones work in humans - findings that one day may help eradicate worm infections that afflict a third of the world's population.

9 Mar 2006

Saliva RNA test for oral cancer

Oral cancer is the 6th most common cancer in men and the 14th most common cancer in women. In the US, oral cancer will be diagnosed in an estimated 30,000 Americans this year and will cause more than 8,000 deaths.

9 Mar 2006

Yale School of Medicine expands research using transcranial magnetic stimulation for schizophrenia

Yale School of Medicine researchers are recruiting patients nationally for a clinical trial using transcranial magnetic stimulation (TMS) to help still the voices that are so troubling to some persons with schizophrenia.

9 Mar 2006

Thalidomide, Lenalidomide show promise against Lou Gehrig's disease

New animal research suggests that two well-studied drugs, thalidomide and its derivative, lenalidomide, might extend the survival of patients with the neurological disorder amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

9 Mar 2006

University of Michigan researchers target stubborn gram-negative bacteria

Ronald Woodard's team set out looking for a way to kill a stubborn type of bacteria and they succeeded - but not in the way he expected.

9 Mar 2006

Whites have higher blood serum levels of perfluorochemicals than Hispanics and blacks

Whites have three times higher blood serum levels of perfluorochemicals (PFCs) than Hispanics and two times higher levels than blacks, according to a study scheduled for publication in the April 1 issue of the American Chemical Society's journal, Environmental Science & Technology.

9 Mar 2006

Nebivolol may restore damaged cardiovascular functions in African Americans

Tadeusz Malinski, Marvin & Ann Dilley White Professor of Chemistry and Biochemistry, found that the drug, currently under review by the U.S. Food and Drug Administration, acts on the level of oxidants lining the cardiovascular system and can restore levels of nitric oxide and reduce oxidative stress.

9 Mar 2006